Add like
Add dislike
Add to saved papers

Reliable patient-reported outcome measure and survivorship of UKA for primary spontaneous osteonecrosis.

PURPOSE: Primary Spontaneous osteonecrosis of the knee (SPONK) was a result of a subchondral insufficiency fracture based on histopathological examinations. There were few studies examining patients who underwent unicompartmental knee arthroplasty (UKA) for the treatment of primary SPONK. The aim of this study was to investigate (1) patient-reported outcome measure (PROM), (2) survivorship of revision as end point and (3) survivorship of complication as end point in patients with primary SPONK.

METHODS: The clinical examinations of a consecutive series of 61 medial UKAs for primary SPONK of the medial femoral condyle from 2008 to 2012 were evaluated retrospectively at our institution. There were 18 males and 43 females with a mean age of 73.7 years (60-91). In all patients, preoperative radiographs were analyzed according to the stage of primary SPONK. We conducted Kaplan-Meier survival analyses using revision and complications for any reasons as the end point.

RESULTS: Mean follow-up was 6.6 years (range 6-10). UKA using Physica ZUK (LIMA Corporate. UD, Italy) for SPONK improved patients' 2011 Knee Society symptom score, patient satisfaction, patient activities, EQ-5D and postoperative ranges of motion compared with their preoperative status (P < 0.01). Revision surgery was required in one knee (1.6%) due to postoperative fracture of the medial tibial plateau after a fall that occurred 6 months postoperatively. The projected rate of survivorship of UKA was 90.4% at 10 years (95% confidence interval 0.80-1). The projected rate of survivorship with complication at end point was 87.7% at 10 years (95% confidence interval 0.76-0.99).

CONCLUSION: The present study demonstrated that primary spontaneous osteonecrosis of the knee (SPONK) can be successfully be treated with UKA at a mean follow-up of 6.6 years.

LEVEL OF EVIDENCE: II.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app